1. Differential seasonal performance of C3-epi-D3 level and proportion on multiple metabolic disorders in patients with type 2 diabetes mellitus
- Author
-
Xiaohong Chen, Bi Peng, Wenchun Ye, Bitao Wu, Qiang Yang, Jie Tang, and Yuwei Yang
- Subjects
Type 2 diabetes mellitus ,Metabolic disorders ,C3-epimer ,25 hydroxyvitamin D3 ,Association ,Medicine - Abstract
Abstract Background and aim Recent Mendelian randomization and meta analysis suggest a controversial causality between C3-epimer of 25 hydroxyvitamin D3 (C3-epi-D3) and type 2 diabetes mellitus (T2DM). The clinical evidence regarding the impact of C3-epi-D3 on the progression of T2DM is currently insufficient. This study aims to investigate whether C3-epi-D3 has any effect on metabolic disorders of T2DM patients. Methods A total of 1222 patients with T2DM were prospectively enrolled in this study and followed up every 1 to 2 months for 3 to 6 months. Kidney biomarkers, lipids, electrolytes, and 25 hydroxyvitamin D (25-OHD) metabolites were measured as required during follow-up, to investigate the association of C3-epi-D3 levels and %C3-epi-D3 with metabolic disorders, including dyslipidemia, chronic kidney disease (CKD), and calcium-phosphorus metabolic disorder. Results Among these T2DM patients, there were age and seasonal differences in C3-epi-D3 levels (χ 2 = 10.419 and 19.609, P = 0.034 and
- Published
- 2024
- Full Text
- View/download PDF